Cochrane Canada is fortunate to draw on the guidance and expertise of the following patient leaders:
In addition to her work with Cochrane, Ms. Lyddiatt serves on the SPOR National Steering Committee, and she is actively involved in patient-oriented research capacity building with the Ontario SPOR SUPPORT Unit.
Ms. Maureen Smith has been a patient leader with Cochrane Canada since 2015. Her extensive background as a consumer representative in the area of evidence-based decision making, which spans nearly two decades, has been an asset to Cochrane.
In addition to her work with Cochrane, Ms. Smith serves as a patient member on Ontario’s Committee to Evaluate Drugs and Health Quality Ontario’s Health Technology Advisory Committee. She is also a member of the Patient-Centered Outcomes Research Institute’s Rare Disease Advisory Panel, as well as an active board member of the Canadian Organization for Rare Disorders.
Ms. Marilyn Walsh has been a patient leader with Cochrane Canada for 10 years. Throughout her affiliation with Cochrane, Ms. Walsh has contributed extensively to the production of evidence syntheses, in addition to assisting with the coordination and implementation of knowledge translation initiatives, for the following groups: Cochrane Musculoskeletal, Cochrane Upper GI and Pancreatic Diseases and Cochrane Back and Neck.
In addition to her work with Cochrane, Ms. Walsh is actively involved with the Canadian Patient Partner in Arthritis program, and serves as Director and Local Branch Leader for the Canadian Spondylitis Association (CSA).